We are live on ! Find out more

206 hedge funds and large institutions have $2.32B invested in Neogen in 2017 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 69 increasing their positions, 81 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more call options, than puts

Call options by funds: $359K | Put options by funds: $200K

50% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 8

6% more capital invested

Capital invested by funds: $2.19B → $2.32B (+$123M)

1% more funds holding

Funds holding: 203206 (+3)

0.36% more ownership

Funds ownership: 234.1%234.46% (+0.36%)

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

15% less repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 81

Holders
206
Holders Change
+3
Holders Change %
+1.48%
% of All Funds
5.14%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.1%
New
12
Increased
69
Reduced
81
Closed
8
Calls
$359K
Puts
$200K
Net Calls
+$159K
Net Calls Change
-$339K

NEOG Hedge Fund Activity: Q2 2017 in Review

206 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Neogen (NEOG) for Q2 2017, worth a combined $2.32B — up 5.6% from $2.19B a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new NEOG positions and 8 closed out — a net gain of 4 holders — while 69 added to existing stakes and 81 trimmed.

The largest buyer was OppenheimerFunds, adding an estimated $6.9M. The largest seller was Riverbridge Partners, cutting an estimated $24.7M.

  • 206 institutional investors held Neogen (NEOG) as of Q2 2017, up from 203 in Q1 2017.
  • Funds reported $2.32B of Neogen stock for Q2 2017, up 5.6% quarter-over-quarter.
  • 12 funds opened new Neogen positions in Q2 2017 and 8 closed out, a net change of +4 holders.
  • The largest Neogen buyer in Q2 2017 was OppenheimerFunds, an estimated $6.9M added.
  • The largest Neogen seller in Q2 2017 was Riverbridge Partners, an estimated $24.7M sold.

Based on aggregated 13F filings for Q2 2017.